http://archive.fast-edgar.com/20261001/AP2ZQ22CZZ2RO2RN229R2MY2A6NQZZ22ZL82
Filed on: October 1, 2026
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 29, 2026
(Exact name of Registrant as Specified in Its Charter)
Delaware
... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Rule 14a-101)
INFORMATION REQUIRED IN
PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 1, 2026
Evommune, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
001-42938
85-0742575
(State or... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K Strategy Inc For: Sep 30
-
Form 424B5 Antelope Enterprise Hold
-
Form 8-K RADNOSTIX INC For: Sep 28
-
Form FWP Hashdex Nasdaq CME Crypt Filed by: Hashdex Nasdaq CME Crypto Index ETF
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: Guse Kyle
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: Sims Andrew John Hugh MacIntyre
-
Form 6-K SILICOM LTD. For: Oct 01
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: HEDRICK MARC H
-
Form 8-K Allarity Therapeutics, For: Sep 30
-
Form 6-K Antelope Enterprise Hold For: Oct 01
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: van Es-Johansson An
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: Hawkins Richard J
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: ANDREWS RONALD ASBURY
-
Form 4 CERENOME, INC. For: Oct 01 Filed by: Clowes Howard
-
Form 6-K Radiopharm Theranostics For: Oct 01
-
Form 8-K NEKTAR THERAPEUTICS For: Oct 01
-
Form 8-K USA Rare Earth, Inc. For: Oct 01
-
Form 425 Armada Acquisition Corp. Filed by: Armada Acquisition Corp. II
-
Form 4 FILANA THERAPEUTICS, For: Sep 29 Filed by: Barry Richard
-
Form 4 Uxin Ltd For: Sep 30 Filed by: Dai Kun
-
Form 8-K Armada Acquisition Corp. For: Sep 30
-
Form 8-K Veritone, Inc. For: Sep 30
-
Form 6-K POWERBANK Corp For: Oct 01
-
Form 8-K Toast, Inc. For: Sep 28
-
Form 8-K Brightline Interactive, For: Oct 01
-
Form 8-K Valion Bio, Inc. For: Sep 30
-
Form 8-K Vylor Inc. For: Oct 01
-
Form 144 ORAMED PHARMACEUTICALS Filed by: Gabay Avraham
-
Form 8-K EIDP, Inc. For: Oct 01 Filed by: Corteva, Inc.
-
Form 144 ORAMED PHARMACEUTICALS Filed by: Hexter Joshua
-
Form 8-K Monte Rosa Therapeutics, For: Oct 01
-
Form SC TO-I/A Arbutus Biopharma Corp Filed by: Arbutus Biopharma Corp
-
Form F-X TSUKISHIMA HOLDINGS CO., Filed by: Mitsubishi Kakoki Kaisha, Ltd.
-
Form 424B3 SCHMID Group N.V.
-
Form 8-K Installed Building Produ For: Oct 01
-
Form 424B3 SCHMID Group N.V.
-
Form 8-K MCCORMICK & CO INC For: Oct 01
-
Form 1-SA RSE Collection, LLC For: Jun 30
-
Form 8-K CHESAPEAKE UTILITIES For: Sep 30
-
Form 8-K CIVISTA BANCSHARES, INC. For: Oct 01
-
Form 8-K FrontView REIT, Inc. For: Oct 01
-
Form 8-K KYNTRA BIO, INC. For: Sep 30
-
Form 3/A CRH PUBLIC LTD CO For: Jul 01 Filed by: Will W Anthony
-
Form 40-17G Bitwise Funds Trust
-
Form 424B3 SCHMID Group N.V.
-
Form 424B3 SCHMID Group N.V.
-
Form 10-12G/A Third Point Private Capi
-
Form CERT T. Rowe Price Exchange-T
-
Form 6-K Arcos Dorados Holdings For: Oct 01
-
Form 8-K ACUITY INC. (DE) For: Oct 01
